ERBB2 and breast cancer: We extend on this by performing our own variant calling, annotation and high affinity binding neoepitope prediction of cancer specific variants for the three breast cancer subtypes (ER/PR(+)HER-2(−), HER-2(+), and TNBC), and found that TNBC has higher mutational burden than other subtypes.